Header Logo

Connection

David Smelson to Serotonin Antagonists

This is a "connection" page, showing publications David Smelson has written about Serotonin Antagonists.
Connection Strength

0.228
  1. Smelson DA, Williams J, Ziedonis D, Sussner BD, Losonczy MF, Engelhart C, Kaune M. A double-blind placebo-controlled pilot study of risperidone for decreasing cue-elicited craving in recently withdrawn cocaine dependent patients. J Subst Abuse Treat. 2004 Jul; 27(1):45-9.
    View in: PubMed
    Score: 0.228
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.